NovaBay Pharmaceuticals
17 hedge funds and large institutions have $1.71M invested in NovaBay Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
28% less capital invested
Capital invested by funds: $2.37M → $1.71M (-$660K)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$68K | |
| 2 | +$48K | |
| 3 | +$47.6K | |
| 4 |
Renaissance Technologies
New York
|
+$31K |
| 5 |
Goldman Sachs
New York
|
+$23.5K |
Top Sellers
| 1 | -$134K | |
| 2 | -$27K | |
| 3 | -$25.3K | |
| 4 |
RBC
Ronald Blue & Co
Roswell,
Georgia
|
-$14K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$2K |